Waddell & Associates’s Gilead Sciences GILD Stock Holding History

Waddell & Associates’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$214K	Sell	1,690 -333	-16%	-$43.9K	0.01%	500
2026 Q1	$282K	Buy	2,023 +317	+19%	+$44.4K	0.02%	348
2025 Q4	$209K	Buy	+1,706	New	+$207K	0.01%	351
2022 Q4	–	Sell	-3,952	Closed	-$244K	–	148
2022 Q3	$244K	Sell	3,952 -761	-16%	-$48K	0.05%	114
2022 Q2	$291K	Buy	4,713 +756	+19%	+$46.8K	0.06%	103
2022 Q1	$235K	Hold	3,957	–	–	0.04%	119
2021 Q4	$287K	Buy	3,957 +85	+2%	+$5.85K	0.05%	97
2021 Q3	$270K	Hold	3,872	–	–	0.05%	90
2021 Q2	$267	Buy	+3,872	New	+$259K	0.04%	102

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Waddell & Associates's GILD Position: Q2 2026 in Review

Waddell & Associates reduced its Gilead Sciences (GILD) stake by 16% in Q2 2026, selling an estimated $43.9K and leaving 1,690 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #500.

Waddell & Associates first reported a position in GILD in Q2 2021 and has held it in 9 quarters since. The position peaked at $291K in Q2 2022. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Waddell & Associates held 1,690 shares of Gilead Sciences worth $214K as of Q2 2026.
Waddell & Associates sold 333 Gilead Sciences shares in Q2 2026, an estimated $43.9K.
Gilead Sciences made up 0.01% of Waddell & Associates's portfolio in Q2 2026, its #500 holding.
Waddell & Associates first reported a position in Gilead Sciences in Q2 2021 and has held it in 9 quarters since.
Waddell & Associates's Gilead Sciences position peaked at $291K in Q2 2022.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.